サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1434272

アンチスカルファント／スケール抑制剤市場：タイプ、用途、エンドユーザー別-2024-2030年の世界予測

Antiscalants / Scale Inhibitors Market by Type (Carboxylates, Fluorides, Phosphate Salts), Application (Boilers, Filters, Heat Exchangers), End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アンチスカルファント／スケール抑制剤市場：タイプ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アンチスカルファント／スケール抑制剤市場規模は2023年に30億3,000万米ドルと推計され、2024年には32億1,000万米ドルに達し、CAGR 5.81%で2030年には45億1,000万米ドルに達すると予測されます。

アンチスカルファント／スケール抑制剤の世界市場

主な市場の統計
基準年[2023］ 30億3,000万米ドル
予測年[2024］ 32億1,000万米ドル
予測年 [2030] 45億1,000万米ドル
CAGR（%） 5.81%
アンチスカルファント／スケール抑制剤 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはアンチスカルファント／スケール抑制剤市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、アンチスカルファント／スケール抑制剤市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-アンチスカルファント／スケール抑制剤市場の市場規模および予測は？

2-アンチスカルファント／スケール抑制剤市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-アンチスカルファント／スケール抑制剤市場における技術動向と規制の枠組みは？

4-アンチスカルファント／スケール抑制剤市場における主要ベンダーの市場シェアは？

5-アンチスカルファント／スケール抑制剤市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • パイプラインの運用効率を向上させるためのスケール防止剤の必要性
      • 水不足に対する懸念の高まりと効果的な水管理ソリューションの必要性
      • 石油・ガス、鉱業での幅広い用途
    • 抑制要因
      • スケール防止剤における化学物質の使用に伴う環境への懸念
    • 機会
      • スケール防止剤技術の進歩
      • 天然およびグリーンスケール抑制剤の開発
    • 課題
      • 腐食防止剤との適合性の問題と代替品の入手可能性
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 アンチスカルファント／スケール抑制剤市場：タイプ別

  • カルボン酸塩
  • フッ化物
  • リン酸塩
  • ホスホネート
  • スルホネート

第7章 アンチスカルファント／スケール抑制剤市場：用途別

  • ボイラー
  • フィルター
  • 熱交換器
  • パイプ
  • チューブ

第8章 アンチスカルファント／スケール抑制剤市場：エンドユーザー別

  • エネルギー生成
  • 飲食品
  • マイニング
  • 石油ガス
  • 上下水処理

第9章 南北アメリカのアンチスカルファント／スケール抑制剤市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のアンチスカルファント／スケール抑制剤市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのアンチスカルファント／スケール抑制剤市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Aquapharm Chemical Pvt. Ltd.
    • Ashland Global Holdings, Inc.
    • BASF SE
    • Brenntag North America, Inc.
    • Chemtex Speciality Limited
    • Clariant AG
    • DuPont de Nemours, Inc.
    • Ecolab Inc.
    • Hydrovida
    • Italmatch AWS SpA
    • Kemira Oyj
    • King Lee Technologies
    • PCC SE
    • PWT Chemicals by H2O Innovation Inc.
    • Shandong IRO Water Treatment Co., Ltd.
    • Shandong Kairui Chemistry Co.,Ltd.
    • Shandong Taihe Technologies Co., Ltd.
    • Shandong ThFine Chemical Co., Ltd.
    • Solenis International LLC
    • Solvay SA
    • Taiyuan Lanlang Technology Industrial Corp.
    • The Dow Chemical Company
    • US Water Systems Inc.
    • Veolia Environnement S.A.
    • Weihai Xiangyu Technology Co., Ltd.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ANTISCALANTS / SCALE INHIBITORS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANTISCALANTS / SCALE INHIBITORS MARKET DYNAMICS
  • FIGURE 7. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ANTISCALANTS / SCALE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ANTISCALANTS / SCALE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANTISCALANTS / SCALE INHIBITORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY CARBOXYLATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY FLUORIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY PHOSPHATE SALTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY PHOSPHONATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY SULFONATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY BOILERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY PIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TUBING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY ENERGY GENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY MINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY OIL & GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY WATER & WASTEWATER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM ANTISCALANTS / SCALE INHIBITORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. ANTISCALANTS / SCALE INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 151. ANTISCALANTS / SCALE INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 152. ANTISCALANTS / SCALE INHIBITORS MARKET LICENSE & PRICING
目次
Product Code: MRR-2A0283E255C7

[195 Pages Report] The Antiscalants / Scale Inhibitors Market size was estimated at USD 3.03 billion in 2023 and expected to reach USD 3.21 billion in 2024, at a CAGR 5.81% to reach USD 4.51 billion by 2030.

Global Antiscalants / Scale Inhibitors Market

KEY MARKET STATISTICS
Base Year [2023] USD 3.03 billion
Estimated Year [2024] USD 3.21 billion
Forecast Year [2030] USD 4.51 billion
CAGR (%) 5.81%
Antiscalants / Scale Inhibitors Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antiscalants / Scale Inhibitors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antiscalants / Scale Inhibitors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antiscalants / Scale Inhibitors Market, highlighting leading vendors and their innovative profiles. These include Aquapharm Chemical Pvt. Ltd., Ashland Global Holdings, Inc., BASF SE, Brenntag North America, Inc., Chemtex Speciality Limited, Clariant AG, DuPont de Nemours, Inc., Ecolab Inc., Hydrovida, Italmatch AWS SpA, Kemira Oyj, King Lee Technologies, PCC SE, PWT Chemicals by H2O Innovation Inc., Shandong IRO Water Treatment Co., Ltd., Shandong Kairui Chemistry Co.,Ltd., Shandong Taihe Technologies Co., Ltd., Shandong ThFine Chemical Co., Ltd., Solenis International LLC, Solvay SA, Taiyuan Lanlang Technology Industrial Corp., The Dow Chemical Company, US Water Systems Inc., Veolia Environnement S.A., and Weihai Xiangyu Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Antiscalants / Scale Inhibitors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Carboxylates
    • Fluorides
    • Phosphate Salts
    • Phosphonates
    • Sulfonates
  • Application
    • Boilers
    • Filters
    • Heat Exchangers
    • Pipes
    • Tubing
  • End-User
    • Energy Generation
    • Food & Beverage
    • Mining
    • Oil & Gas
    • Water & Wastewater Treatment
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Antiscalants / Scale Inhibitors Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antiscalants / Scale Inhibitors Market?

3. What are the technology trends and regulatory frameworks in the Antiscalants / Scale Inhibitors Market?

4. What is the market share of the leading vendors in the Antiscalants / Scale Inhibitors Market?

5. Which modes and strategic moves are suitable for entering the Antiscalants / Scale Inhibitors Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antiscalants / Scale Inhibitors Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for antiscalants to improve operational efficiency of pipelines
      • 5.1.1.2. Rising concern over water scarcity and need for effective water management solutions
      • 5.1.1.3. Widespread application in oil and gas and mining industry
    • 5.1.2. Restraints
      • 5.1.2.1. Environmental concerns associated with the use of chemicals in scale inhibitors
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in the scale inhibitor technology
      • 5.1.3.2. Development of natural and green scale inhibitors
    • 5.1.4. Challenges
      • 5.1.4.1. Compatibility issues with corrosion inhibitors and availability of alternatives
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Antiscalants / Scale Inhibitors Market, by Type

  • 6.1. Introduction
  • 6.2. Carboxylates
  • 6.3. Fluorides
  • 6.4. Phosphate Salts
  • 6.5. Phosphonates
  • 6.6. Sulfonates

7. Antiscalants / Scale Inhibitors Market, by Application

  • 7.1. Introduction
  • 7.2. Boilers
  • 7.3. Filters
  • 7.4. Heat Exchangers
  • 7.5. Pipes
  • 7.6. Tubing

8. Antiscalants / Scale Inhibitors Market, by End-User

  • 8.1. Introduction
  • 8.2. Energy Generation
  • 8.3. Food & Beverage
  • 8.4. Mining
  • 8.5. Oil & Gas
  • 8.6. Water & Wastewater Treatment

9. Americas Antiscalants / Scale Inhibitors Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antiscalants / Scale Inhibitors Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antiscalants / Scale Inhibitors Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Aquapharm Chemical Pvt. Ltd.
    • 13.1.2. Ashland Global Holdings, Inc.
    • 13.1.3. BASF SE
    • 13.1.4. Brenntag North America, Inc.
    • 13.1.5. Chemtex Speciality Limited
    • 13.1.6. Clariant AG
    • 13.1.7. DuPont de Nemours, Inc.
    • 13.1.8. Ecolab Inc.
    • 13.1.9. Hydrovida
    • 13.1.10. Italmatch AWS SpA
    • 13.1.11. Kemira Oyj
    • 13.1.12. King Lee Technologies
    • 13.1.13. PCC SE
    • 13.1.14. PWT Chemicals by H2O Innovation Inc.
    • 13.1.15. Shandong IRO Water Treatment Co., Ltd.
    • 13.1.16. Shandong Kairui Chemistry Co.,Ltd.
    • 13.1.17. Shandong Taihe Technologies Co., Ltd.
    • 13.1.18. Shandong ThFine Chemical Co., Ltd.
    • 13.1.19. Solenis International LLC
    • 13.1.20. Solvay SA
    • 13.1.21. Taiyuan Lanlang Technology Industrial Corp.
    • 13.1.22. The Dow Chemical Company
    • 13.1.23. US Water Systems Inc.
    • 13.1.24. Veolia Environnement S.A.
    • 13.1.25. Weihai Xiangyu Technology Co., Ltd.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing